The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer.
Lily L. Lai
No relevant relationships to disclose
Ken Chiu
No relevant relationships to disclose
Vincent M. Chung
No relevant relationships to disclose
Dean Lim
No relevant relationships to disclose
Joseph Chao
No relevant relationships to disclose
Paul Henry Frankel
No relevant relationships to disclose
Stephen Shibata
No relevant relationships to disclose